NSNasa Sinnott-Armstrong

Nasa Sinnott-Armstrong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nasa Sinnott-Armstrong has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Genomics for chronic overlapping pain conditions

    by Michael Wainberg, Nasa Sinnott-Armstrong, Daniel J. Clauw, Frances M. K. Williams

  • Open Access

    GWAS of Lyme disease identifies five loci and discovers a connection with post-infectious diseases

    by Satu Strausz, Erika Romppanen, Hele Haapaniemi, Finn Gen, Estonian Biobank Research team, Health Informatics Research Team, Richa Saxena, Nasa Sinnit-Armstrong, Erik Abner, Hanna M Ollila

    Lyme disease is a vector-borne bacterial infection with marked heterogeneity in susceptibility and clinical manifestations. We investigated the genetic architecture and clinical heterogeneity of Lyme disease using genetic and longitudinal health data from FinnGen and the Estonian Biobank. Genome-wide association analyses included 37,571 individuals with Lyme disease and 670,567 controls (N = 708,138), complemented by sex-stratified analyses and temporal phenotyping in FinnGen. The overall GWAS meta-analysis identified three genome-wide significant loci at SCGB1D2 , TLR1/TLR6 , and HLA-DQA1 . Sex-stratified analyses identified additional genome-wide significant signals at CPE in males (β = −0.077, P = 2.99 × 10⁻⁸) and the TYMP-CPT1B locus in females (β = −0.064, P = 4.98 × 10⁻⁸). The TLR1/6 association was more pronounced in males (β = −0.141, P = 2.16 × 10⁻¹²) than in females (β = −0.060, P = 1.21 × 10⁻⁵). Temporal phenotyping showed enrichment of neurological, musculoskeletal, and dermatological manifestations after Lyme disease diagnosis, with associations generally attenuating over time. Bell palsy showed the strongest association at 1-6 months (OR 11.49, P = 2.37 × 10⁻⁷⁹), while joint pain was also enriched during this interval (OR 1.74, P = 1.95 × 10⁻²³). Early associations with joint pain and Bell palsy were stronger in males than in females. These findings expand the genetic architecture of Lyme disease, implicate innate immune sensing through the TLR1/TLR6 locus, and antigen presentation through the HLA associations. Overall, the results highlight a strong polygenic signal with Lyme disease and a connection with other post-infectious clinical manifestations.

  • Open Access

    Large language model-based bibliometric evaluation of population descriptors in human genetics

    by Stephanie M. Gogarten, Daphne O. Martschenko, Roshni Patel, Nasa Sinnott-Armstrong

    As the use of population descriptors such as race, ethnicity, and ancestry have become increasingly common in modern genetics research, there have been growing calls to critically examine their use. Most notably, in 2023, the National Academies of Science, Engineering, and Medicine (NASEM) published a report titled Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field , which included eight specific and actionable recommendations for researchers to implement the ethical and accurate use of population descriptors in genetic research. Here, we use the 2023 NASEM report as a benchmark to analyze the use of population descriptors in genome-wide association studies (GWAS). We develop a general toolkit for large language model-based bibliometrics, operationalize the report’s recommendations into an evaluation framework, and apply this framework to evaluate all 4,007 papers from the GWAS Catalog published between 2007 and 2025 with full text available on PubMedCentral. We find significant improvements in adherence to NASEM report recommendations over time. However, most improvements predate the publication of the NASEM report itself, suggesting the report functioned primarily as a synthesis of existing best practices rather than a catalyst for change. We conclude by highlighting opportunities for growth in the field of human genetics.

  • Open Access

    Estrogen interactions with breast cancer risk variants in regulatory DNA

    by Ibtihal M Elfaki, Laura Kellman, Robin Meyers, Luca Ducoli, Martina Fu, Kamal Obbad, Smarajit Mondal, Xue Yang, Douglas F Porter, David Reynolds, et al.

    Insight into population-level gene-environment (GxE) interactions is a major goal in understanding polygenic diseases, such as breast cancer. We integrated massively parallel reporter assays (MPRA), chromatin profiling, and network analysis to identify estrogen-responsive breast cancer variants. Screening 1,604 GWAS-identified breast cancer variants identified 73 estrogen-modulated SNVs (emSNVs). Chromatin accessibility modeling validated allele-specific effects, identifying variants that disrupt pioneer factor binding to chromatin and others that modulate transcription factor (TF) recruitment to pre-accessible enhancers. emSNV targets converged on pathways including mitochondrial metabolism, NF-κB signaling, and chromatin regulation. Aggregating emSNVs into a polygenic risk score (PRSE2) revealed interactions with reproductive risk factors in 13,026 post-menopausal BRCA cases and 108,265 controls, including age at first birth (p=0.0052); a control PRS lacking estrogen-responsive variants showed no interactions. This framework bridges molecular and epidemiological GxE studies to uncover variants whose disease associations depend on environmental context, with implications for understanding polygenic disease risk.

  • Top Cited Papers
    Open Access

    The genetic architecture of fibromyalgia across 2.5 million individuals

    by Isabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, Lea Urpa, Hele Haapaniemi, Gudmar Thorleifsson, Lilja Stefansdottir, Stephan Frangakis, Jesse Valliere, Lovemore Kunorozva, et al.

    Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including DCC , DRD2 / NCAM1 , MDGA2 and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This study provides robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.


  • Open Access

    Genetic variants affect diurnal glucose levels throughout the day

    by Nasa Sinnott-Armstrong, Satu Strausz, Lea Urpa, Erik Abner, Josephine P. Johnson, Jesse Valliere, Teele Palumaa, Finn Gen, Va Million Veteran Program, Priit Palta, et al.

    Circadian rhythms not only coordinate the timing of wake and sleep but also regulate homeostasis within the body, including glucose metabolism. The genetic variants that contribute to the temporal control of glucose levels have not been previously examined. Using genome-wide data from ~420,000 individuals from the UK Biobank and replication in ~100,000 individuals from the Estonian Biobank, ~500,000 from FinnGen, ~160,000 from the VA Million Veteran Program, and ~52,000 from the MGB Biobank, we show that glucose levels are under diurnal genetic control. We discover a robust temporal association of glucose levels at the Melatonin receptor 1B ( MTNR1B , rs10830963, P = 1×10 −22 ) and a canonical circadian pacemaker gene Cryptochrome 2 ( CRY2) loci (rs12419690, P = 1×10 −16 ). Furthermore, we show that sleep modulates glucose levels, and the genetic variants have an independent role in diurnal glucose control. Finally, we show that these variants independently modulate risk of type 2 diabetes and that sleep medications including melatonin associate with type 2 diabetes. Our findings, together with earlier genetic and epidemiological evidence, show a clear connection between sleep and metabolism and highlight genetic variation at MTNR1B and CRY2 in the control of diurnal glucose levels.

  • Open Access

    Meta-analysis of Cannabis Use Identifies Shared Genetic Loci with Sleep and Circadian Rhythms

    by Jesse Valliere, Satu Strausz, Cynthia Tchio, Oona Shigeno Risse-Adams, Nasa Sinnott-Armstrong, Hanna M Ollila, Richa Saxena

    Cannabis use is an increasingly common therapeutic for a variety of chronic diseases. In addition, people with sleep problems may self-medicate using cannabis products. However, genetic architecture of cannabis use and its shared genetic predispositions with sleep traits has not been systematically examined. We performed a meta-analysis of cannabis use within the All of Us and UK Biobank cohorts, consisting of 152,807 cases and 220,272 controls. Our meta-analysis identified 39 independent loci, including the previously reported CADM2 locus associated with cannabis use and replicating previous work. Additionally our associations include neuronal and sleep-regulating genes such as HTR1A, RAI1, SLC39A8 , and NCAM1 . Moreover, tissue-specific analyses revealed that the genetic architecture of cannabis use is heavily enriched within the central nervous system and specific brain cell types. In addition, we observed significant positive genetic correlations with clinical insomnia, insomnia-related medication usage, and objectively measured nighttime physical activity, alongside negative correlations with morningness chronotype and daytime activity. Fine-mapping and colocalization analyses identified shared genetic signals between cannabis use and clinical insomnia including a near-perfect colocalization at SLC39A8 and CADM2 . Together, these results highlight the shared genetic risk between cannabis use and sleep disorders. Additionally, our findings indicate the importance of investigating the genetic effects of cannabis use as its use becomes more widespread, both recreationally and medicinally.

  • Open Access

    Participatory-informed preference optimization (PiPrO): A reinforcement learning simulation study

    by Tara Templin, Shuyi Song, Sophia Fort, Nasa Sinnott-Armstrong

    Artificial intelligence (AI) has transformative potential in public health, but its impact is limited by models that implicitly prioritize a single stakeholder perspective and do not make explicit and tunable trade-offs between community and clinician endorsement. To address this gap, we introduce Participatory-informed Preference Optimization (PiPrO), a large language model embedding-based calibration framework that generates a single clinical outcome prediction while explicitly accounting for differences between community and physician interpretations of the same scenario. PiPrO takes as input two embeddings derived from a large language model representing a community-facing context and a physician-facing context. It then applies a shared lightweight feedforward predictor to produce per-stakeholder scores which are then mixed using a single global mixing weight (alpha). Alpha controls how strongly the final prediction reflects the community versus physician responses and is learned using a policy-gradient update driven by an abundant but noisy community text and a sparse and biased physician text. PiPrO reliably learned stable alpha values and a consistent reward signal. Alpha shifts systematically toward physician weighting as community feedback becomes noisier and shifts toward community weighting as physician feedback becomes more biased. Our results suggest PiPrO’s potential to produce more transparent, and context-sensitive AI-driven healthcare recommendations. Future research should validate this approach using real-world community inputs to ensure generalizability and practical impact.


  • Open Access

    The genetic architecture of fibromyalgia across 2.5 million individuals

    by Isabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, Lea Urpa, Hele Haapaniemi, Gudmar Thorleifsson, Lilja Stefansdottir, Stephan Frangakis, Jesse Valliere, Lovemore Kunorozva, et al.

    Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here, we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying the first 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including CAMKV , DCC , DRD2 / NCAM1 , MDGA2 , and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric, and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.


  • Open Access

    An emergent disease-associated motor neuron state precedes cell death in a mouse model of ALS

    by Olivia Gautier, Jacob A. Blum, Thao P. Nguyen, Sandy Klemm, Mai Yamakawa, Nasa Sinnott-Armstrong, Yi Zeng, Chung-Ha O. Davis, Juliane Bombosch, Lisa Nakayama, et al.

    Summary: To uncover molecular determinants of motor neuron degeneration and selective vulnerability in amyotrophic lateral sclerosis (ALS), we generated longitudinal single-nucleus transcriptomes and chromatin accessibility profiles of spinal motor neurons from the SOD1-G93A ALS mouse model. Vulnerable alpha motor neurons showed thousands of molecular changes, marking a transition into a novel cell state we named ‘disease-associated motor neurons’ (DAMNs). We identified transcription factor regulatory networks that govern how healthy cells transition into DAMNs as well as those linked to vulnerable and resistant motor neuron subtypes. Using spatial transcriptomics, we found reactive glia located near motor neurons early in disease, suggesting early signaling events between motor neurons and glia. Finally, we found that the human orthologs of genomic regions with differential accessibility in SOD1-G93A alpha motor neurons are enriched for single nucleotide polymorphisms associated with human ALS, providing evidence that the genetic underpinnings of motor neuron vulnerability are conserved.